Form 8-K - Current report:
SEC Accession No. 0001437749-13-001861
Filing Date
2013-02-22
Accepted
2013-02-22 15:01:47
Documents
4
Period of Report
2013-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K immucore_8k-021913.htm 8-K 29102
2 EX. 10.1 ex10-1.htm EX-10.1 112767
3 EX. 10.2 ex10-2.htm EX-10.2 191876
4 EX. 10.3 ex10-3.htm EX-10.3 78468
  Complete submission text file 0001437749-13-001861.txt   413476
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-14820 | Film No.: 13633919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances